6,7,3\',4\'-Tetrahydroxyaurone 6-O-(3\'\',4\'\',6\'\'-tri-O-acetylglucoside)



Compound IDCDAMM02763
Common name6,7,3\',4\'-Tetrahydroxyaurone 6-O-(3\'\',4\'\',6\'\'-tri-O-acetylglucoside)
IUPAC name[3,4-diacetyloxy-6-[[2-[(3,4-dihydroxyphenyl)methylidene]-7-hydroxy-3-oxo-1-benzofuran-6-yl]oxy]-5-hydroxyoxan-2-yl]methyl acetate
Molecular formulaC27H26O14

Experimental data

Retention time13.15
Adduct[M+H]+
Actual mz575.138
Theoretical mz575.139
Error3.09
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.5721

Identifiers and class information

Inchi keyAHLQXSOCSBYAFH-NWKMRQQTNA-N
SmilesO=C(OCC1OC(OC2=CC=C3C(=O)C(OC3=C2O)=CC4=CC=C(O)C(O)=C4)C(O)C(OC(=O)C)C1OC(=O)C)C
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)4
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)12
Number of reactive functional groups (#rtvFG)4
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)574.494
Computed dipole moment(dipole)3.994
Total solvent accessible surface area (SASA)886.675
Hydrophobic component of SASA (FOSA)323.112
Hydrophilic component of SASA (FISA)354.166
Pie component of the SASA (PISA)209.397
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1633.77
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)14.9
Free energy of solvation of dipole (dip^2/V)0.009763
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0336087
Globularity descriptor (glob)0.756592
Predicted polarizability in cubic angstroms (QPpolrz)53.524
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.582
Predicted octanol/gas partition coefficient (QPlogPoct)32.54
Predicted water/gas partition coefficient (QPlogPw)23.574
Predicted octanol/water partition coefficient (QPlogPo/w)0.783
Predicted aqueous solubility (QPlogS)-5.018
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.746
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.469
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)4.339
Predicted brain/blood partition coefficient (QPlogBB)-4.285
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1.382
Predicted skin permeability, log Kp (QPlogKp)-6.157
PM3 calculated ionization potential (IP(ev))8.838
PM3 calculated electron affinity (EA(eV))1.354
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-0.416
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)17.019
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)240.475
Number of nitrogen and oxygen atoms (#NandO)14
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O43570CA12Carbonic anhydrase XIIT16987SEA
Q16790CA9Carbonic anhydrase IXT64567SEA
P00915CA1Carbonic anhydrase IT13201SEA
P00918CA2Carbonic anhydrase IIT20401SEA
Q9ULX7CA14Carbonic anhydrase XIVT31992SEA
P05121SERPINE1Plasminogen activator inhibitor-1T15556SEA
Q9NUW8TDP1Tyrosyl-DNA phosphodiesterase 1T33492SEA
O43826SLC37A4Glucose-6-phosphate translocaseT47306SEA
Q99417MYCBPMYCBP messenger RNAT37298SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
T64567DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q16790CA9
T13201DI0166Glaucoma[ICD-11: 9C61]P00915CA1
T13201DI0372Seborrhoeic dermatitis[ICD-11: EA81]P00915CA1
T20401DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P00918CA2
T20401DI0137Essential hypertension[ICD-11: BA00]P00918CA2
T20401DI0166Glaucoma[ICD-11: 9C61]P00918CA2
T20401DI0175Heart failure[ICD-11: BD10-BD1Z]P00918CA2
T20401DI0214Insomnia[ICD-11: 7A00-7A0Z]P00918CA2
T20401DI0372Seborrhoeic dermatitis[ICD-11: EA81]P00918CA2
T31992DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q9ULX7CA14
T31992DI0204Inborn metabolism deficiency[ICD-11: 5C50-5C59]Q9ULX7CA14
T15556DI0037Asthma[ICD-11: CA23]P05121SERPINE1
T15556DI0405Thrombosis[ICD-11: DB61-GB90]P05121SERPINE1
T37298DI0235Liver cancer[ICD-11: 2C12]Q99417MYCBP

Copyright © 2025